Novasys Secures $50 Million in Series D Financing
Novasys Medical, the developer of Renessa, a non-surgical treatment for female stress urinary incontinence (SUI), secured $45 million in Series D preferred stock financing.
The round was led by Versant Ventures, with ThreeArch Partners and Skyline Ventures also participating as new investors.
Money will be used to further development and commercialization efforts of Renessa.
Veran Medical Secures $5 Million to Launch Cancer Device
Veran Medical Technologies, a privately held image-guided medical device company, secured $5 million in venture capital and private financing to drive adoption of its IG4 delivery system for minimally invasive biopsy and ablation of cancer. St. Louis-based Prolog Ventures led the round and was joined by Advantage Capital Partners and existing private investors.
CyDen Raises Funds to Expand Marketing of iPulse
CyDen, a pioneer of intense pulsed light (IPL) technology, received a $5 million capital injection from Unilever Ventures in a new round of investment managed by Longbow Capital.
CyDen’s iPulse range of products miniaturizes and simplifies light-based treatments for permanent hair reduction, acne, skin blemishes, pigmentation as well as phototherapy for anti-aging and wrinkle reduction.
The small and portable IPL devices deliver safe and effective results at lower energy levels providing Spa business owners a reliable and cost-effective entry into the lucrative aesthetic and beauty market.